Clinical <i>Talaromyces marneffei</i> isolates exhibit enhanced stress tolerance and diminished antifungal responsiveness relative to non-clinical strains. [PDF]
Pan KS +5 more
europepmc +1 more source
Diagnosis, treatment, and biosafety protection of imported highly pathogenic cutaneous fungal infection: a case-based study of cutaneous coccidioidomycosis. [PDF]
Weng Y, Liu Z, Xia X.
europepmc +1 more source
Micafungin microevolution in <i>Candida auris</i> reveals resistance development without <i>in vivo</i> fitness compromise. [PDF]
Bohner F +5 more
europepmc +1 more source
Case Report: High-altitude exposure and severe respiratory infection precipitating diabetic ketoacidosis: new-onset ketosis-prone diabetes unmasked by physiological stress. [PDF]
Briones-Claudett KH +7 more
europepmc +1 more source
<i>In silico</i> identification of isosilybin a targeting squalene epoxidase as an antifungal adjuvant with <i>in vitro</i> validation against azole-resistant <i>Candida</i> and emerging yeasts. [PDF]
Mundhe AK, Rajkumari R.
europepmc +1 more source
Iron modulation drives biofilm formation and virulence enzyme production in emerging clinical <i>Candida</i> species: implications for diagnostics and therapeutics. [PDF]
Kumari S +6 more
europepmc +1 more source
Antifungal susceptibility, FKS1 gene expression, and virulence determinants of Candida albicans in pediatric and neonatal candidiasis. [PDF]
Rezaei-Mojaz M +7 more
europepmc +1 more source
Six-month surveillance of <i>Candida parapsilosis</i> in Tyrol, Austria: high-risk ST11 lineage and early, heterogeneous fluconazole resistance. [PDF]
Steixner S +4 more
europepmc +1 more source
mSphere of Influence: Diagnosis of antifungal tolerance and persistence. [PDF]
Chen L.
europepmc +1 more source
Identification of efflux inhibitors through a drug repurposing strategy in <i>Candida albicans</i>. [PDF]
Marques D, Costa SS, Rodrigues L.
europepmc +1 more source

